Trastuzumab Recruiting Phase 1 Trials for Inflammatory carcinoma of the breast Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01880385Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer